Kimyasal ve Farmasötikal Sanayi’de kamu programı evrimi

Arcadis’in anahtar karar vericiler tarafından Kimyasal ve Farmasötikal Sanayi’de kamu programı üzerine gerçekleştirmiş olduğu anket

Martijn Karrenbeld

Sector Leader Chemicals & Pharmaceuticals Europe +31 20 2011085 Ask me a question

Commoditization, public sector austerity, feedstock prices and creating a new pipeline of products are some of the major challenges facing the chemical and pharmaceutical industries today.  Global organizations operating in these sectors must continue to innovate with cutting-edge research and development and flexible manufacturing, while seeking to enter new markets.  The significant investment required to do so must deliver the most cost effective, desired outcomes to programs - now more than ever.

Arcadis recently surveyed the senior property executives from several of the world’s largest chemical and pharmaceutical organizations on their capital delivery priorities, their current and future intended position of their capital delivery models, and enablers and barriers for improved capital delivery.

The survey identified that organizations are on a journey in the development of their capital delivery models.  60% of respondents are already well on their journey to significantly outsource and all respondents foresaw implementing further outsource initiatives.  80% intend to reach a position where most functions are outsourced in the foreseeable future.

Meanwhile, organizations believe there are still significant changes to be made in their journey toward:

  • centralization of the supply chain
  • centralization of asset knowledge for use by the organization
  • a shift from a transactional mind-set to more collaborative forms of working both internally and with the supply chain.


What we found is that  that some organizations may be initiating significant business change without fully understanding the implications, or without putting the necessary capabilities in place to drive the change. These organizations might run the risk of losing momentum in their change program.

A recurrent theme from the survey is that organizations are not only lacking in confidence in the availability of resource from the supply chain, but are also concerned that they do not have the capability to secure all benefits from their suppliers. The two issues are interlinked and it may be necessary for internal investment to make best use of supply chain capability to meet wider performance improvement targets.

These findings are significant, as capital delivery functions become leaner internally while more complex as they transition to an intelligent client capability. The organization’s internal team should focus on stakeholder needs and the challenges associated with the delivery of business outcomes in complex, fast-moving organizations.

For the full results of the survey, download the report below. 

Bu makale hakkındaki sorular

Martijn Karrenbeld

Sector Leader Chemicals & Pharmaceuticals Europe +31 20 2011085 Ask me a question

Arcadis tanıtım belgesi

Değişim için Katalizör

Buradan indirebilirsiniz